Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Abdel Rahman Al Tahan"'
Autor:
Abdel Rahman Al Tahan, Peter Rieckmann, Hussien Qahtani, Jihad Inshasi, Abu Bakr Madani, Saeed Bohlega
Publikováno v:
Journal of Neurology
The epidemiology of multiple sclerosis (MS) is rapidly changing in many parts of the world. Based on the Kurtzke classification, the Arabian Gulf Region is located in a low-risk zone for MS; however, recent studies suggest a moderate-to-high prevalen
Autor:
Jihad Inshasi, Mohammed Al Jumah, Maurice Dahdaleh, Abdel Rahman Al Tahan, Dirk Deleu, Miklos Szolics, I. Alsharoqi, Ahmad Khalifa, Saeed Bohlega, Bassem Yamout
Publikováno v:
International Journal of Neuroscience. 121:171-175
Treatment adherence to disease modifying drugs (DMDs) in multiple sclerosis is sub-optimal. This, in turn, can affect patients' long-term responses to therapy. A key factor that influences treatment adherence is the need for self-injection of DMDs, w
Autor:
Abdel-Rahman Al Tahan
Publikováno v:
Archives of Medical Research. 31:101-104
Background Antiepileptics including benzodiazepines have long been recognized to provoke seizures and precipitate status epilepticus occasionally. This has a special clinical importance in the case of diazepam because of its use as first choice medic
Autor:
R. Zaidan, Abdel-Rahman Al Tahan
Publikováno v:
Clinical Infectious Diseases. 28:399-405
Autor:
Bassem Yamout, Jihad Inshasi, Abdel Rahman Al-Tahan, Suhail Al-Shammri, Ahmad Khalifa, Mohammed Al Jumah, Maurice Dahdaleh, Isa Al Sharoqi, Miklos Szolics, Dirk Deleu, Saeed Bohlega
Publikováno v:
The International journal of neuroscience. 120(4)
Adherence to therapy is a key issue in chronic illnesses. In addition, several features of multiple sclerosis (MS) and its treatment may increase the likelihood of patient nonadherence and discontinuation of treatment. Nonadherence will obviously com